Sponsored Content|Blog|Contrast Media Injectors| February 28, 2022

BLOG: Advanced Injector System Provides Greater Control and Accelerates Patient Care

EmpowerMR Injector System

Bracco's EmpowerMR injector system on display at RSNA 2021.

Medical imaging and contrast use have become an integral part of the diagnostic process to determine the best individually tailored treatments. This, in turn, has driven demand for innovative injector systems that offer greater control, more safety features, dependable performance and ease of use.

Dedicated to patient safety and meeting the demands of today’s advanced MR procedures,Bracco Diagnostics Inc.presented itsEmpowerMR Injector Systemat the2021 Radiological Society of North America (RSNA)conference in Chicago.

EmpowerMR Injector System

Part of Bracco’sSmartInject technology suite灌顶MR注入器系统是一种液压驱动的磁共振(MR)注入器,具有许多先进的功能,提高了使用的便捷性,最终转化为安全、成功的操作程序和操作人员的安心。该系统提供了一个全面的方法,以确保磁共振成像的安全性和图像质量。

Rated for use with 1.5T, 3T, and up to 7T scanners, the injector system helps capture optimal images.

"The EmpowerMR is a highly efficient injector system,” said Chad Durling, senior manager, device marketing for Bracco Diagnostics Inc. “It is unique in that it is battery-free and powered by an innovative hydraulic system, which works with vegetable oil (yes, that is correct), that is safe for the environment, and not generate a magnetic field due to its low voltage DC components. This means minimizing radiofrequency transients and frequency distortions.”

Driving Safety and Efficiency

TheEmpowerMRimproves clinical workflow and helps healthcare professions do more while delivering the best possible care to patients. The system offers a full range of integrated features that are designed to drive safety and efficiency, including:

  • An ARM mode allows the software to run diagnostic checks prior to injection, as well as guard against unintentionally starting the injection.
  • A tilt lockout helps minimize the risk of air embolism by ensuring that the injector runs only in the down position.
  • A color-coded illuminating handle lets you know whether the injector RAM is in motion
  • A KVO feature provides added assurance that the patient's vein remains open.
  • If an overpressure condition occurs in this mode, the system automatically pauses the injection and notifies the technologist to check for occlusion.
  • 注入头与扫描孔的距离没有限制。
  • Color-coded keys on either side of the injector handle allow you to test, arm, run and stop the injector from whichever side is more accessible.
  • A remote with a color LCD display panel featuring visual prompts to guide you through the process and soft keys to control the injection procedure from the control room.
  • A user-friendly remote display with anatomical identifiers allows easy viewing and programming of protocols
  • The system stores up to 50 separate contrast protocols.

“All of these features allow technologists to be in full control of the patient,” Durling explained. “Additionally, the color-coded handle changes from orange to blue based on whether it is injecting contrast or saline—providing good visualization if you are outside of the room. You can see when you are injecting contrast and when you are injecting saline.”

Simplicity and Flexibility

Featuring a user-friendly remote interface and easily accessible help function that provides instant on-screen operational guidance, the system is designed with simplicity and flexibility of use in mind. Its dual initialize-and-replace syringe improves clinical workflow and increases productivity and eGFR calculator helps calculate the optimal volume of contrast for kidney-impaired patients further enhancing safety measures.

In addition, each EmpowerMR Injector System comes with a 24/7 technical support, and locally based technicians are available to provide on-site preventive maintenance, service, and repair.

“Simply put, the EmpowerMR injector system is a very dependable and user-friendly injector. If you have technologists who are cross-training between CT and MR systems, it is a very easy transition between the two user interfaces—an added benefit to our customers, especially nowadays when healthcare providers are pressed to do more with less and staff is filling multiple roles,” Durling said.

Editor’s note:This blog is the third of a four-part series on smart injection technology. The first blog, Smart Injector Technology Delivers Effective and Efficient Patient Care, can be foundhere.The second blog, Patient-centric Injector Solutions Help CT Departments Take Control, Improve Safety, can be foundhere.

Related Content

EHR screenshot showing sidebar text displayed to referring clinicians after placing orders for body CT (neck, chest, or abdomen and pelvis), describing iohexol shortage and providing appropriate strategies for iodinated contrast media conservation.
News|Contrast Media

2022年8月3日——根据ARRS《美国x射线学杂志》(AJR)的一篇开放获取文章,电子健康……

TimeAugust 03, 2022
arrow
Bracco Diagnostics has announced that the U.S. Food and Drug Administration (FDA) granted import discretion of Iomeron® (iomeprol injection) into the U.S. to address the ongoing iodinated contrast media shortage.
News|Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

TimeAugust 02, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News|Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

TimeJuly 18, 2022
arrow
The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.
Feature|Contrast Media

The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...

TimeMay 03, 2022
arrow
Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.
Sponsored Content|Case Study|Contrast Media Injectors

产品适应症和用途:克拉里斯康(gadoterate meglamine)是一种基于钆的造影剂,用于…

TimeMay 03, 2022
arrow
2021年2月,Guerbet宣布推出OptiProtect 3S(智能服务解决方案),为其注入解决方案提供一系列技术服务。OptiProtect 3S设计用于支持成像中心的日常使用和保护其注射解决方案。
Feature|Contrast Media Injectors| By Melinda Taschetta-Millane

造影剂注射器用于注射造影剂以增强组织的血液和灌注。有……

TimeJanuary 19, 2022
arrow
The global contrast media market size is expected to reach USD 7.2 billion by 2028 and is expected to expand at a CAGR of 8.6% from 2021 to 2028.
News|Contrast Media

December 30, 2021 — The "Global Contrast Media Market Size, Share & Trends Analysis Report by Product Type (Iodinated ...

TimeDecember 30, 2021
arrow
Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.
News|Contrast Media Injectors

December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to ...

TimeDecember 13, 2021
arrow
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI
News|Contrast Media Injectors

2021年9月16日- FDB (First Databank),一家领先的药物和医疗设备知识提供商,帮助医疗保健…

TimeSeptember 16, 2021
arrow
The contrast agents global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence and prevalence of chronic diseases and demand for diagnostic and interventional radiology procedures, increase in aging population, expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement
News|Contrast Media

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

TimeMay 03, 2021
arrow
Subscribe Now